» Articles » PMID: 31478735

Molecular and Restriction Fragment Length Polymorphism Analysis of Canine Parvovirus 2 (CPV-2) in Dogs in Southeast Anatolia, Turkey

Overview
Date 2019 Sep 4
PMID 31478735
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Canine parvovirus-2 (CPV-2) is the aetiological agent of an infectious viral disease of dogs, characterised by diarrhoea and vomiting. Mutations of the CPV-2 genome have generated new variants circulating worldwide. This article reports the molecular analysis of CPV-2 variants collected in the dog population in southeast Anatolia, Turkey. Twenty blood samples previously taken for the laboratory diagnosis of dogs with suspected parvovirus were screened for CPV-2 by polymerase chain reaction (PCR). Of the 20 samples, 18 tested positive for CPV-2. Partial VP2 gene sequencing and restriction fragment length polymorphism (RFLP) analysis revealed CPV-2a (n = 1), CPV-2b (n = 16) and CPV-2c (n = 1) variants. Phylogenetic analysis based on the partial length VP2 gene showed that CPV-2b (n = 15) variants showed sequences clustering separately in the phylogenetic tree. The CPV-2c sample was phylogenetically related to Chinese strains and Indonesia strain, whereas the CPV-2a sample was phylogenetically related to the Portuguese strain. These results, which are the first to demonstrate the presence of CPV-2c in the dog population of southeast Anatolia, Turkey, indicate that CPV-2a/2b/2c variants co-exist in Turkey's dog population.

Citing Articles

Comparison of the sequences of the viral capsid protein 1 and viral capsid protein 2 encoded genes in symptomatic and asymptomatic cases of canine parvovirus 2 in dogs.

Al-Saadi M, Nubgan A, Abbas A Vet World. 2025; 18(1):8-14.

PMID: 40041507 PMC: 11873395. DOI: 10.14202/vetworld.2025.8-14.


First identification of canine parvovirus -2a/2b variant in unvaccinated domestic dogs with gastrointestinal signs in Türkiye.

Saltik H, Koc B Vet Med Sci. 2024; 10(4):e1523.

PMID: 38958584 PMC: 11221316. DOI: 10.1002/vms3.1523.


Clinical and inflammatory response to antiviral treatments in dogs with parvoviral enteritis.

Ulas N, Ozkanlar Y, Ozkanlar S, Timurkan M, Aydin H J Vet Sci. 2024; 25(1):e11.

PMID: 38311324 PMC: 10839179. DOI: 10.4142/jvs.23139.


Canine Parvovirus in Turkey: First Whole-Genome Sequences, Strain Distribution, and Prevalence.

Temizkan M, Sevinc Temizkan S Viruses. 2023; 15(4).

PMID: 37112937 PMC: 10145800. DOI: 10.3390/v15040957.


Phylogenetic analysis of canine parvovirus isolates from west Mediterranean region of Türkiye.

Hasircioglu S Vet Res Forum. 2023; 14(3):113-119.

PMID: 37033776 PMC: 10073807. DOI: 10.30466/vrf.2022.545086.3328.


References
1.
Ikeda Y, Mochizuki M, Naito R, Nakamura K, Miyazawa T, Mikami T . Predominance of canine parvovirus (CPV) in unvaccinated cat populations and emergence of new antigenic types of CPVs in cats. Virology. 2000; 278(1):13-9. DOI: 10.1006/viro.2000.0653. View

2.
Pratelli A, Cavalli A, Martella V, Tempesta M, Decaro N, Carmichael L . Canine parvovirus (CPV) vaccination: comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine. Clin Diagn Lab Immunol. 2001; 8(3):612-5. PMC: 96110. DOI: 10.1128/CDLI.8.3.612-615.2001. View

3.
Battilani M, Scagliarini A, Tisato E, Turilli C, Jacoboni I, Casadio R . Analysis of canine parvovirus sequences from wolves and dogs isolated in Italy. J Gen Virol. 2001; 82(Pt 7):1555-1560. DOI: 10.1099/0022-1317-82-7-1555. View

4.
Buonavoglia C, Martella V, Pratelli A, Tempesta M, Cavalli A, Buonavoglia D . Evidence for evolution of canine parvovirus type 2 in Italy. J Gen Virol. 2001; 82(Pt 12):3021-3025. DOI: 10.1099/0022-1317-82-12-3021. View

5.
Nakamura M, Tohya Y, Miyazawa T, Mochizuki M, Phung H, Nguyen N . A novel antigenic variant of Canine parvovirus from a Vietnamese dog. Arch Virol. 2004; 149(11):2261-9. DOI: 10.1007/s00705-004-0367-y. View